scispace - formally typeset
M

M. Paul Murphy

Researcher at Mayo Clinic

Publications -  14
Citations -  6212

M. Paul Murphy is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Presenilin & Amyloid precursor protein secretase. The author has an hindex of 12, co-authored 14 publications receiving 5763 citations.

Papers
More filters
Journal ArticleDOI

Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular Aβ and Synaptic Dysfunction

TL;DR: The recapitulation of salient features of AD in these mice clarifies the relationships between Abeta, synaptic dysfunction, and tangles and provides a valuable model for evaluating potential AD therapeutics as the impact on both lesions can be assessed.
Journal ArticleDOI

γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase

TL;DR: A subsequent cleavage by γ-secretase that releases the ErbB-4 intracellular domain from the membrane and facilitates its translocation to the nucleus is reported.
Journal ArticleDOI

Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

TL;DR: Transgenic models that express Abeta1-40 or Abeta2-42 in the absence of human amyloid beta protein precursor (APP) overexpression establish that Abeta 1-42 is essential for amyloids deposition in the parenchyma and also in vessels.
Journal ArticleDOI

A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP

TL;DR: The findings indicate that the AICD regulates phosphoinositide-mediated calcium signaling through a γ-secretase-dependent signaling pathway, suggesting that the intramembranous proteolysis of APP may play a signaling role analogous to that of Notch.
Journal ArticleDOI

Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/- Knock-Out Mice

TL;DR: It is concluded that after Aβ immunization, the effects of anti-Aβ antibodies on Aβ deposition in APP Tg2576 transgenic mice are not dependent on FcR-mediated phagocytic events.